Regarding the evaluation of ALK and ROS1 gene rearrangements, IHC/ICC was employed in the vast majority of cases (n = 78, 92.9%), whereas RNA-based NGS analysis was adopted in only n = 6 (7.1%) instances. This evidence concerns the gene ROS1 and intrahepatic cholangiocarcinoma.